From an academic background in France with interest in controlling programmed cell death in industrial processes, Dr. Angelo Perani has moved to industry to work on process development and cell line development at Lonza UK followed by a move to Australia to manage a production facility and cell biology group for the Ludwig Institute for Cancer Research and the Olivia Newton John Cancer Research Institute followed by heading the scientific operations of a biosimilar company (NeuClone) and successfully taken 2 products to Phase I clinical trials under TGA. Dr. Perani has a positive vision of the impact of biotechnology assisting medical progress and maintaining a sustainable world.

Shruti is a seasoned professional with extensive experience in the financial sector, advertising, sales promotion, business development, and customer relationships. Her impressive background includes working with top multinational banks in India, such as ICICI, HSBC, and HDFC. Shruti has a proven track record in business development and customer relationship management, having worked with these leading banks in India. Her expertise lies in providing tailored banking solutions and managing financial portfolios for clients. As the Founder and CFO, Shruti brings her vast experience, skills, and passion to drive business growth, customer satisfaction, and financial excellence.